A Regulatory Partner for Complex MedTech and IVD Challenges
Built to support MedTech teams facing critical regulatory decisions, compressed timelines, and increasing scrutiny
Most regulatory problems do not arrive with much warning.
A Notified Body query lands on a Friday afternoon. An MDR submission timeline suddenly compresses. An internal team that was managing well finds itself one product launch away from being genuinely stretched.
SciMed exists for exactly these moments.
Since 2015, we have worked as an independent regulatory partner to medical device and IVD manufacturers navigating high-stakes decisions internationally. We bring together clinical science, engineering, and regulatory expertise to help clients build documentation and submissions that hold up under scrutiny, and support a clear path to market.
Our view has not changed in a decade: regulatory compliance should strengthen your commercial progress, not obstruct it.
Companies do not call us when everything is running smoothly. They call when a Notified Body query is threatening momentum, when MDR or IVDR timelines are tightening, and when a submission needs to be right with little time left to correct it.
We know this territory well. And we know what it costs when regulatory work stalls.
Ready to Discuss your Regulatory Priorities?
Whether you are approaching a submission deadline, responding to a Notified Body query, or strengthening your regulatory position, we can help you assess the next step with clarity and avoid costly delays.
Why MedTech Teams Trust SciMed
Over 1,000 international regulatory submissions have passed through SciMed's hands. That number matters not as a headline, but because of what it represents: a team that has seen how Notified Body reviewers think, where documentation tends to fall short, and what separates a submission that moves forward from one that does not.
In 2020, that capability was tested under conditions that left no room for error. SciMed conducted the clinical evaluations for emergency ventilators deployed at NHS Nightingale hospitals during the COVID-19 pandemic. Speed was essential. So was scientific integrity. Both were delivered.
Our Managing Director, Dr Alastair Selby, is an active participant in the ISO working groups shaping clinical evaluation, risk management, and biological safety standards. He also serves on a UK parliamentary advisory group on medical devices.
For our clients, this means regulatory changes are not surprises.
They are anticipated, understood, and built into strategy before they affect submissions.
Speak to a team that understands how your submission will be reviewed – before it is submitted.
How We Work
Every engagement is organised around three principles. Not because they sound good on a page, but because they reflect how regulatory work actually needs to function under pressure.
Scientific Rigour that stands up to scrutiny
We assess your regulatory documents and clinical evidence with the same critical lens a Notified Body reviewer will apply. Gaps are identified early, when they can still be addressed, rather than surfacing as audit findings or submission delays when the stakes are higher.
Structured Documentation built for inspection
A sound regulatory strategy is only as strong as the documentation behind it. We design technical files and submission packages that are clear, defensible, and audit-ready across the full product lifecycle.
Partnership that Extends Beyond Delivery
We work as an extension of your internal team. When questions arise, deadlines shift, or feedback returns from regulators, we help you respond quickly and effectively.
What This Looks Like in Practice
When a global contact lens manufacturer faced the MDR transition, their internal team was not under-skilled. They were under-resourced for the scale of what the transition actually required.
SciMed came in and led the regulatory strategy from end to end. We developed their clinical and biological evaluation plans, structured their technical documentation, and supported the full Notified Body submission process.
The outcome was not simply a completed submission. It was a clear, manageable path through a regulatory transition that had already stalled far larger internal teams at other organisations. Their documentation was audit-ready. Their timeline held.
This approach, methodical, evidence-based, and aligned to commercial timelines, is what we bring to every project. Whether that is a first CE mark application, a complex performance evaluation for a high-risk IVD, or a post-market technical file that needs to be in better shape before a Notified Body review.
A Partner That Tells You Early, Not Late
Regulatory consultancies are not difficult to find. What is more difficult to find is a partner who will tell you honestly when something in your documentation will not hold up, and then work with you to fix it before it affects your timeline or your approval status.
That is how we operate.
From the first conversation, we prioritise clear communication, practical advice, and honest assessment. When audits or submission deadlines are approaching, we do not manage the situation remotely. We work alongside your team to resolve issues and strengthen your regulatory position.
For our clients, the goal is not simply to complete a report or submit a file.
It is to move forward with greater confidence: clearer documentation, a stronger regulatory strategy, and a team better prepared for what comes next.
Ready to Move Forward with Clarity?
If you are navigating a complex submission, responding to regulatory feedback, or preparing for your next stage of growth, the right next step is a direct, informed conversation.